1

Specialty Drugs Reference CatalogSummer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

2Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

Distribution you can count on

• Over 17,000 pharmaceuticals in stock nationwide

• Drug Supply Chain Security Act (DSCSA)-compliant

• Reliable multi-channel communications platform

• Real-time access to purchasing data and product documents

• Safe storage and fast professional delivery

Contents

Featured Product >

ZILRETTA® is the first and only FDA-approved extended-release intra-articular therapy for osteoarthritis-related knee pain utilizing microsphere technology.

Get to know ZILRETTA®

Pharmaceutical Programs >

Serving Outpatient Care >

New Products >

Hyaluronic Acid (HA) Injections >

Women’s Health >

Featured Product >

Manufacturer Billing Resources >

Professional Resources >

Product Listing >

3Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional Resources Product Listing

Contents

Pharmaceutical programsChildhood and adult vaccines

• We have the vaccines you need for adults and pediatrics

• One order to place for all supplies on one invoice

• Save on shipping and receive next day delivery on orders

• Confidently order what you need and return expired vaccines, if necessary.

• All necessary DSCSA regulatory data maintained easily on McKesson SupplyManagerSM

Influenza vaccines Let McKesson FluWise® help you get ready for flu, with our comprehensive, year-round program giving you access to a variety of flu products, savings and support every step of the way.

When you order flu vaccines from us, you get:

• No limit on shipping locations per order

• Dedicated flu team

• Extended terms

• Seasonal supplies

• Year-round promotional offers

Contact your McKesson Account Manager or visit mms.mckesson.com or call 866.625.2679

Pharmaceutical Programs

Specialty drugsDon’t have time to keep up with the changes and all the new products?

We do. Our priority is making sure your practice is up to date and benefits from safe medical distribution, ordering efficiency, reliable communications, and stable pricing programs. All these options will help you create a more personalized patient experience.

6 in 10 adults in the US have chronic disease1

We distribute more pharmaceutical products to alternate care settings than any other distributor and with every order, you can count on choice, reliable distribution, smart solutions and a team of experts at your side.

Explore our growing specialty drugs portfolio and helpful resources with this interactive catalog.

GenericsNo matter your care setting we have the generics you need, including:

• Corticosteroids

• Analgesics

• Anti-infectives

• Anesthetics

• Cardiovascular agents

• Ophthalmic agents

• Hormone agents and suppressants

• And more!

Pharmaceutical services• CSOS – Electronic CII Ordering

• McKesson Business Analytics

• Pharmaceutical Disposal

• SDS Reporting

4Specialty Drugs Catalog | Summer 2020

HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

Serving Outpatient Care

Committed to outpatient care

Orthopedics1% Sodium HyaluronateDUROLANE®

EUFLEXXA®

GenVisc® 850Gel-One®

GELSYN-3®

HYALGAN®

HYMOVIS®

Orthovisc®

Monovisc®

SUPARTZ-FX®

Synvisc®

Synvisc One®

TRILURON™

TriVisc®

Visco-3™

ZILRETTA®

Family Practice/ Internal Medicine/ Multi SpecialtyBotox®

EVENITY®

Otiprio®

Prolia®

Daptomycin®

Ertapenem®

ZINPLAVA®

CardiologyLexiscan®

NeurologyBOTOX® (Therapeutic)Lioresal®

UrologyBOTOX®

Firmagon®

ELIGARD®

OB/GYNSkyla®

Kyleena®

Mirena®

LILETTA®

Prolia®

EVENITY®

Surgery CenterAnjeso®

Dextenza®

EXPAREL®

DEXYCU®

Otiprio®

Distribution designed to address the unique needs of independent practices, large groups and complex health systems.

We continue to add products and support for over 100 primary care and specialized outpatient care settings. See complete list of products here.

A fleet delivering 5 days a week

Next-day deliveryto 95% of the United States95%

Over 17,000 pharmaceuticalsin stock nationwide

99.8% order accuracy

5Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s Health Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

New Products

New productsTRILURON™ McKesson Item Number: 1153617

Manufacturer Fidia Pharma has introduced TRILURON™ (sodium hyaluronate), a three-injection hyaluronic acid (HA) based intra-articular viscosupplements treatment.

The chemical formulation of TRILURON™ is identical to Hyalgan®, Fidia’s five-injection regimen.

TRILURON™ is used in orthopedic pain management.

• HCPCS Code: J7332

DEXYCU®

McKesson Item Number: 1160736

DEXYCU® (dexamethasone intraocular suspension 9%) is the FDA-approved, single-dose, sustained release, intracameral steroid for the treatment of cataract post-operative inflammation.

DEXYCU® is injected into the eye at the end of eye surgery and its effects may last up to 30 days.

DEXYCU® is used in surgery centers.

• HCPCS Code: J1095

See updated Package Insert for full prescribing information including warnings, precautions and side effects.

See updated Package Insert for full prescribing information including warnings, precautions and side effects.

6Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

HA Injections

Hyaluronic acid (HA) injectionsDeciding on the right sodium hyaluronate (HA) injection for your patients can be difficult. Especially when you are weighing clinical benefits, patient profiles and product reimbursement. Our broad portfolio of HA injections can help support the diverse needs of your practice.

Manufacturer updates• Fidia launches TRILURON®, a 3-injection therapy to join 2-injection

Hymovis® and 5-injection Hyalgan®. View revised Package Insert.

• McKesson is now administering GPO contracts on Synvisc® and Synvisc-One®.

Sodium Hyaluronate (HA) Injections

Product Item Number ManufacturerInjections

Per TherapyReimbursement

CodePackage

Insert

DUROLANE® 1088743 Bioventus 1x J7318

Gel-One® 896819 Zimmer 1x J7326

Synvisc-One® 696400 Sanofi 1x J7328

HYMOVIS® 1056253 Fidia 2x J7322

GELSYN-3™ 1037328 Bioventus 3x J7328

1% Sodium Hyaluronate 1140016 Teva 3x J7331

EUFLEXXA® 1032307 Ferring 3x J7323

Synvisc® 340307 Sanofi 3x J7328

Visco-3™ 1094393 Zimmer 3x J7333

TriVisc® 1124261 OrthogenRx 3x J7329

TRILURON™ 1153617 Fidia 3x J7332

HYALGAN® 1032048/1032049 Fidia 5x J7321

GenVisc® 850 1073894 OrthogenRx 5x J7320

SUPARTZ-FX® 532271 Bioventus 5x J7321

NEW

Distributing viscosupplementation (hyaluronic acid) injectable treatments to:

• Orthopedics

• Pain management clinics

• Physical therapy

• Multi-specialty groups

• Rheumatology

• Family practice

• Health systems

• And more

7Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA InjectionsNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

Women’s Health

Women’s healthThere is a good chance your patients learn about new therapies before you. We can help you stay in-the-know on manufacturer updates and new products that can help you create a personalized patient experience.

Manufacturer updates• LILETTA® receives FDA approval for extended use for up to 6 years.

Read the Press Release.

• Bayer IUD’s are levonorgestrel-releasing intrauterine systems. Mirena® prevents heavy menstrual bleeding and pregnancy for up to 5 years. Kyleena® prevents pregnancy for up to 5 years. Skyla prevents pregnancy for up to 3 years. Bayer has a submission with the FDA to extend the duration of use for Mirena for up to 6 years – we continue to watch for changes.

Bone Health

Product Item Number ManufacturerReimbursement

CodePackage

Insert

Prolia® 729015 Amgen J0897

EVENITY™ 1133836 Amgen J3111

Intrauterine Devices (IUDs)

Product Item Number ManufacturerReimbursement

CodePackage

Insert

Mirena® 1126374 Bayer J7298

Kyleena® 1126376 Bayer J7296

Skyla® 1126375 Bayer J7301

LILETTA® 1058636 Allergan J2797

Distributing women’s health medications and therapies to:

• OB/GYN

• Multi-specialty clinics

• Community health clinics

• Internal medicine

• Family practice

• Endocrinology

• Orthopedics

• And more

Black Box Warning

8Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

Featured Product

Featured productZILRETTA®

McKesson Item Number: 1134726

ZILRETTA® is the FDA-approved extended-release intra-articular therapy for osteoarthritis-related knee pain utilizing microsphere technology.

In December 2019 the Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) that includes and updated Limitation of Use statement for repeat administration among other changes.

• HCPCS Code: J3304

See updated Package Insert for full prescribing information including warnings, precautions and side effects.

Osteoarthritis

Risk factors• Age (those 50+

are most at risk)• Joint injury• Overuse• Obesity

Patient Impact• Pain• Depression• Activity limitations• Work limitations

OA increases the risk of developing heart disease by 50%2

• Weak muscles• Genetic disposition• Gender (women

are most likely to develop OA)

9Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Professional ResourcesPharmaceutical Programs Product Listing

Contents

Billing Resources

Manufacturer billing resourcesBilling and coding information for your practice.

1% Sodium HyaluronateBilling Resource

Dextenza®

Billing Resource

DEXYCU®

Billing Resource

DUROLANE®

Billing Resource

EUFLEXXA®

Billing Resource

EXPAREL®

Billing Resource

GenVisc® 850Billing Resource

GELSYN-3™

Billing Resource

Gel One® and Visco-3®

Billing Resource

HYALGAN®

Billing Resource

HYMOVIS®

Billing Resource

Lexiscan®

Billing Resource

Lioresal®

Billing Resource

Otiprio®

Billing Resource

Looking for a billing resource not listed above? Let your McKesson Account Manager know and we’ll contact the manufacturer right away!

Prolia® and EVENITY®

Billing Resource

SUPARTZ-FX®

Billing Resource

Synvisc and Synvisc-OneBilling Resource

TRILURON™

Billing Resource

Trivisc®

Billing Resource

ZILRETTA®

Billing Resource

ZINPLAVA™

Billing Resource

10Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing ResourcesPharmaceutical Programs Product Listing

Contents

Professional Resources

Professional resourcesProtecting and improving Medicare for our nation’s seniors

Drug Supply Chain Security Act (DSCSA)DSCSA is administered by the Food and Drug Administration (FDA) and has these objectives:

• Pharmaceutical drug integrity

• Traceability of drugs through supply chain

• A system of unique product identifiers

• Robust transaction history and information

• Efficient verification requests, responses to suspect/illegitimate products, effective recalls as needed

• National licensure standards for wholesale distributors and third-party logistics organizations

Next Nov. 27, 2020, primary care providers and other dispensers may only accept products with valid Product Identifier.

Visit the FDA DSCSA Website for more information.

McKesson Medical-Surgical is DSCSA compliant.

Under Executive Order #13890, titled Protecting and Improving Medicare for Our Nation’s Seniors (specifically under Section 5), the Centers for Medicare and Medicaid Services (CMS), plans to propose reform to the Medicare program that would significantly impact Physician Assistants (PAs) and Advanced Practicing Registered Nurses (APRNs).

On January 17, 2020, the American College of Cardiology provided a written response to CMS outlining specific examples of cardiologic services that APPs should be able to provide under general physician supervision. Read the ASC Letter.

11Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs

Contents

Product Listing

All specialty pharmaceuticals

Product McKesson Item Numbers Manufacturer Reimbursement

Code

1% Sodium Hyaluronate 1140016 Teva J7331

BOTOX® (Therapeutic) 349702, 766957 Allergan J0585

Daptomycin 1129400 Sagent J0878

Daptomycin 1150791 NORTHSTAR J0878

Dextenza® 1137737, 1137736 Ocular Therapeutix J1096

DEXYCU® 1160736 EyePoint J1095

DUROLANE® 1088743 Bioventus J7318

Ertapenem 1112299, 1110229 Multiple J1335

EUFLEXXA® 1032307 Ferring J7323

EVENITY® 1133836 Amgen J3490/J3590

EXPAREL® 1055498, 806793, 1055711, 1055705 Pacira C9290

Firmagon® 870063, 916966 Ferring J9155

Gel-One® 896819 Zimmer J7326

Gelsyn-3™ 1037328 Bioventus J7328

GenVisc® 850 1073894 OrthogenRx J7320

HYALGAN® 1032048, 1032049 Fidia J7321

Product McKesson Item Numbers Manufacturer Reimbursement

Code

HYMOVIS® 1056253 Fidia J7322

Kyleena® 1126376 Bayer J7296

Lexiscan® 665602 Astellas J2785

LILETTA® 1058636 Allergan J7297

Lioresal®1113452, 1113453, 1113454, 1113455, 1113456, 1113457

Saol Contact MFG

Mirena® 1126374 Bayer J7298

Otiprio® 1083735 Otonomy J7342

Prolia® 729015 Amgen J0897

Skyla® 1126375 Bayer J7301

SUPARTZ-FX® 532271 Bioventus J7321

Synvisc® 340307 Sanofi J7325

Synvisc-One® 696400 Sanofi J7325

TRILURON™ 1153617 Fidia J7332

TriVisc™ 1124261 Orthogenix J7329

Visco-3™ 1094393 Zimmer J7321

ZILRETTA® 1134726 Flexion J3304

ZINPLAVA™ 1069979 Merck J0565

Our industry leading portfolio of pharmaceuticals.

12Specialty Drugs Catalog | Summer 2020

Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing

Contents

McKesson is providing HCPCS/ CPT codes based upon information provided by the product manufacturers. McKesson does not make representations about the accuracy of this information. The HCPCS/ CPT codes do not indicate coverage or payment under any federal or state health care program. The entity that submits claims to any federal or state health care program has the responsibility to verify the accuracy of HCPCS/ CPT codes it submits for payment purposes.

The product information contained in this document, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers and have not been independently verified by McKesson Medical-Surgical or its affiliates (“McKesson”). McKesson is not responsible for errors or omissions in the product information. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Caution should be exercised when using or purchasing any products from McKesson’s online or print documents by closely examining the product packaging and the labeling prior to use. Due to product changes, information listed in this document is subject to change without notice. This information is placed solely for your convenience in ordering and McKesson disclaims all responsibility for its completeness and accuracy, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.

All trademarks and registered trademarks are the property of their respective owners. Actual savings may vary based upon products selected and other factors.

© 2020 McKesson Medical-Surgical Inc. 2020-0049

1https://cdc.gov/chronicdisease/about/index2https://oaaction.unc.edu/oa-module/oa-prevalence-and-burden/